Immunovant (IMVT) Prepaid Assets (2019 - 2026)

Immunovant has reported Prepaid Assets for 8 years, with the latest figure at $42.8 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets fell 16.45% year-over-year to $42.8 million; the trailing twelve-month figure through Mar 2026 stood at $42.8 million (down 16.45% YoY), and the FY2026 full-year result was $42.8 million, down 16.45% from the prior year.
• Prepaid Assets for Q1 2026 stood at $42.8 million, down from $46.8 million in the prior quarter.
• The five-year high for Prepaid Assets was $51.2 million in Q1 2025, with the low at $6.3 million in Q1 2022.
• Historically, Prepaid Assets has averaged $29.7 million across 5 years, with a median of $26.6 million in 2024.
• Annual changes were most pronounced in 2022 — Prepaid Assets dropped 18.96% — and 2023, when it jumped 330.45%.
• Immunovant's Prepaid Assets stood at $21.1 million in 2022, then retreated by 10.9% to $18.8 million in 2023, then jumped by 89.43% to $35.6 million in 2024, then jumped by 31.26% to $46.8 million in 2025, then fell by 8.57% to $42.8 million in 2026.
• The last three Prepaid Assets figures came in at $42.8 million (Q1 2026), $46.8 million (Q4 2025), and $49.7 million (Q3 2025), per Business Quant data.